Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 18Other 2

Conditions

Mucositis 44Obesity 23Neoplasms 19Head and Neck Neoplasms 15Stomatitis 12Dyspnea 12Constipation 10Sexual Dysfunction, Physiological 8Squamous Cell Carcinoma of Head and Neck 7Breast Neoplasms 7Overweight 6Xerostomia 5Prostatic Neoplasms 5Radiation Injuries 4Opioid-Induced Constipation 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Pain 3Nausea 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Multiple Myeloma 2Mouth Diseases 2Leukemia 2Intestinal Diseases 2Infertility 2Febrile Neutropenia 2

Interventions

Tirzepatide 1Progestins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Endometrial Hyperplasia × Other × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT05903131 2026-01-20

Uterine Preservation Via Lifestyle Transformation

Washington University School of Medicine

Phase 2 Recruiting
96 enrolled
GynecologicOther

Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡